Abdalla Maya, Elalami Rim, Cho Michael H, O'Connor George T, Rice Mary, Horowitz Michael, Akhoundi Neda, Yen Andrew, Kalhan Ravi, Diaz Alejandro A
Division of Pulmonary and Critical Care, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Division of Pulmonary and Critical Care, Department of Medicine, Harvard Medical School, Boston, MA, USA.
J Clin Exp Pathol. 2024;14(3). Epub 2024 May 24.
Mucus pathology plays a critical role in airway diseases like Chronic Bronchitis (CB) and Chronic Obstructive Pulmonary Disease (COPD). Up to 32% of community-living persons report clinical manifestations of mucus pathology (e.g., cough and sputum production). However, airway mucus pathology has not been systematically studied in community-living individuals. In this study, we will use an objective, reproducible assessment of mucus pathology on chest Computed Tomography (CT) scans from community-living individuals participating in the Coronary Artery Risk Development in Young Adults (CARDIA) and Framingham Heart Study (FHS) cohorts.
We will determine the clinical relevance of CT-based mucus plugs and modifiable and genetic risk and protective factors associated with this process. We will evaluate the associations of mucus plugs with lung function, respiratory symptoms, and chronic bronchitis and examine whether 5-yr. persistent CT-based mucus plugs are associated with the decline in FEV1 and future COPD. Also, we will assess whether modifiable factors, including air pollution and marijuana smoking are associated with increased odds of CT-based mucus plugs and whether cardiorespiratory fitness is related in an opposing manner. Finally, we will determine genetic resilience/susceptibility to mucus pathology. We will use CT data from the FHS and CARDIA cohorts and genome-wide sequencing data from the TOPMed initiative to identify common and rare variants associated with CT-based mucus plugging.
The Mass General Brigham Institutional Review Board approved the study. Findings will be disseminated through peer-reviewed journals and at professional conferences.
Determine whether the presence of CT-based mucus plugs is associated with lung health impairment, including reduced FEV1, more respiratory symptoms, and asthma. Identify modifiable risk and protective factors, such as pollution, exercise, smoking, and fitness that are associated with mucus plugs.
黏液病理学在慢性支气管炎(CB)和慢性阻塞性肺疾病(COPD)等气道疾病中起着关键作用。高达32%的社区居民报告有黏液病理学的临床表现(如咳嗽和咳痰)。然而,社区居民中的气道黏液病理学尚未得到系统研究。在本研究中,我们将对参与青年成人冠状动脉风险发展研究(CARDIA)和弗雷明汉心脏研究(FHS)队列的社区居民的胸部计算机断层扫描(CT)图像进行客观、可重复的黏液病理学评估。
我们将确定基于CT的黏液栓的临床相关性以及与此过程相关的可改变和遗传风险及保护因素。我们将评估黏液栓与肺功能、呼吸道症状和慢性支气管炎的关联,并检查基于CT的5年持续性黏液栓是否与第一秒用力呼气容积(FEV1)下降和未来的慢性阻塞性肺疾病有关。此外,我们将评估包括空气污染和吸食大麻在内的可改变因素是否与基于CT的黏液栓几率增加有关,以及心肺适能是否以相反方式相关。最后,我们将确定对黏液病理学的遗传恢复力/易感性。我们将使用来自FHS和CARDIA队列的CT数据以及TOPMed计划的全基因组测序数据来识别与基于CT的黏液阻塞相关的常见和罕见变异。
麻省总医院布莱根分院机构审查委员会批准了该研究。研究结果将通过同行评审期刊和专业会议进行传播。
确定基于CT的黏液栓的存在是否与肺健康损害相关,包括FEV1降低、更多呼吸道症状和哮喘。识别与黏液栓相关的可改变风险和保护因素,如污染、运动、吸烟和适能。